Cowan Chad 4

What Happened Chad Cowan, Chief Scientific Officer of Century Therapeutics (IPSC), had 358 shares withheld by the company to satisfy tax-withholding obligations tied to the vesting of restricted stock units. The withholding occurred on 2026-06-11 at an effective price of $2.24 per share, totaling about $802. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date: 2026-06-11; withholding price reported at $2.24 per share.
• Shares withheld/disposed: 358 shares; total value ≈ $802.
• Transaction type/code: F — shares withheld to satisfy tax withholding on RSU vesting.
• Shares owned after transaction: Not disclosed in the provided report.
• Filing date/accession: Form 4 filed 2026-06-15 (filed within the typical 2-business-day window following the 6/11 transaction).
• Footnotes:
  • F1: Issuer withheld shares to satisfy tax withholding obligations on RSU vesting.
  • F2: Certain shares are held by the Cowan Investment Nominee Trust; the reporting person disclaims beneficial ownership except for any pecuniary interest.

Context This action reflects a routine cashless settlement/tax-withholding step when RSUs vest and is common among insiders; it should not be interpreted as a discretionary sale indicating sentiment about the company. The transaction reduced outstanding shares held by the insider only to cover taxes—no open-market sale or purchase occurred.